Deciphering the interplay between SETD2 mediated H3K36me3 and RNA N6-methyladenosine in clear cell renal cell carcinoma (ccRCC)
RNA N6-methyladenosine (m6A) plays diverse roles in RNA metabolism and its deregulation contributes to tumor initiation and progression. Clear cell renal cell carcinoma (ccRCC) is characterized by near ubiquitous loss of VHL followed by mutations in epigenetic regulators PBRM1, SETD2, and BAP1. Muta...
Saved in:
| Main Authors: | Shafiq Shaikh, Xia Zhao, Ryan T. Wagner, Xiaoyu Pan, Ryan A. Hlady, Liguo Wang, Thai H. Ho, Keith D. Robertson |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2025-12-01
|
| Series: | Epigenetics |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/15592294.2025.2456418 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Emerging role of SETD2 in the development and function of immune cells
by: Longmin Chen, et al.
Published: (2025-11-01) -
SETD2 loss-of-function uniquely sensitizes cells to epigenetic targeting of NSD1-directed H3K36 methylation
by: Ryan T. Wagner, et al.
Published: (2025-02-01) -
Non-enzymatic SETD1A activity drives breast cancer cell proliferation via cyclin K
by: Kanako Hayashi, et al.
Published: (2025-08-01) -
N6-methyladenosine in DNA promotes genome stability
by: Brooke A Conti, et al.
Published: (2025-04-01) -
SETD2 loss of function is a recurrent event in advanced‐phase chronic myeloid leukemia and contributes to genomic instability
by: Manuela Mancini, et al.
Published: (2025-04-01)